These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 7591626)

  • 21. Prevention of pericyte ghost formation in retinal capillaries of galactose-fed dogs by aldose reductase inhibitors.
    Kador PF; Akagi Y; Terubayashi H; Wyman M; Kinoshita JH
    Arch Ophthalmol; 1988 Aug; 106(8):1099-102. PubMed ID: 3401138
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aldose reductase and pericyte-endothelial cell contacts in retina and optic nerve.
    Robison WG; Nagata M; Tillis TN; Laver N; Kinoshita JH
    Invest Ophthalmol Vis Sci; 1989 Nov; 30(11):2293-9. PubMed ID: 2509396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of aldose reductase inhibitors and galactose withdrawal on fluorescein angiographic lesions in galactose-fed dogs.
    Cusick M; Chew EY; Ferris F; Cox TA; Chan CC; Kador PF
    Arch Ophthalmol; 2003 Dec; 121(12):1745-51. PubMed ID: 14662595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A selective aldose reductase inhibitor of a new structural class prevents or reverses early retinal abnormalities in experimental diabetic retinopathy.
    Sun W; Oates PJ; Coutcher JB; Gerhardinger C; Lorenzi M
    Diabetes; 2006 Oct; 55(10):2757-62. PubMed ID: 17003340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Islet transplantation inhibits diabetic retinopathy in the sucrose-fed diabetic Cohen rat.
    Hammes HP; Klinzing I; Wiegand S; Bretzel RG; Cohen AM; Federlin K
    Invest Ophthalmol Vis Sci; 1993 May; 34(6):2092-6. PubMed ID: 8491559
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Iris vasculopathy in galactose-fed rats.
    Caspers-Velu LE; Wadhwani KC; Rapoport SI; Kador PF
    Exp Eye Res; 1999 Feb; 68(2):211-21. PubMed ID: 10068486
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discordant effects of the aldose reductase inhibitor, sorbinil, on vascular structure and function in chronically diabetic and galactosemic rats.
    Tilton RG; Pugliese G; LaRose LS; Faller AM; Chang K; Province MA; Williamson JR
    J Diabet Complications; 1991; 5(4):230-7. PubMed ID: 1779018
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of aldose reductase inhibitors on the progression of retinopathy in galactose-fed dogs.
    Akagi Y; Kador PF
    Exp Eye Res; 1990 Jun; 50(6):635-9. PubMed ID: 2115453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of topical administration of an aldose reductase inhibitor on cataract formation in dogs fed a diet high in galactose.
    Kador PF; Betts D; Wyman M; Blessing K; Randazzo J
    Am J Vet Res; 2006 Oct; 67(10):1783-7. PubMed ID: 17014334
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased ocular blood flow and 125I-albumin permeation in galactose-fed rats: inhibition by sorbinil.
    Tilton RG; Chang K; Weigel C; Eades D; Sherman WR; Kilo C; Williamson JR
    Invest Ophthalmol Vis Sci; 1988 Jun; 29(6):861-8. PubMed ID: 3372163
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative analysis of retinal vessel changes in galactose-fed dogs.
    Takahashi Y; Augustin W; Wyman M; Kador PF
    J Ocul Pharmacol; 1993; 9(3):257-69. PubMed ID: 8228533
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of sorbitol dehydrogenase inhibition on sugar cataract formation in galactose-fed and diabetic rats.
    Kador PF; Inoue J; Secchi EF; Lizak MJ; Rodriguez L; Mori K; Greentree W; Blessing K; Lackner PA; Sato S
    Exp Eye Res; 1998 Aug; 67(2):203-8. PubMed ID: 9733586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diabetic complications in lens and nerve and their prevention by sulindac or sorbinil: two novel aldose reductase inhibitors.
    Jacobson M; Sharma YR; Cotlier E; Hollander JD
    Invest Ophthalmol Vis Sci; 1983 Oct; 24(10):1426-9. PubMed ID: 6413448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition in rat of development of in utero galactose-induced cataract by an aldose reductase inhibitor--a light microscopic study.
    Teshima R; Taura T; Okamura R
    Jpn J Ophthalmol; 1991; 35(3):317-24. PubMed ID: 1770672
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of in utero galactose-induced cataract development by an aldose reductase inhibitor in rat--electron microscopic study.
    Teshima R; Taura T; Okamura R
    Jpn J Ophthalmol; 1993; 37(2):192-8. PubMed ID: 8230845
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progression of sugar cataract in the dog.
    Sato S; Takahashi Y; Wyman M; Kador PF
    Invest Ophthalmol Vis Sci; 1991 May; 32(6):1925-31. PubMed ID: 1903366
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diabetic-like retinopathy: early and late intervention therapies in galactose-fed rats.
    Robison WG; Jacot JL; Glover JP; Basso MD; Hohman TC
    Invest Ophthalmol Vis Sci; 1998 Sep; 39(10):1933-41. PubMed ID: 9727416
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diabetic-like corneal sensitivity loss in galactose-fed rats ameliorated with aldose reductase inhibitors.
    Jacot JL; Hosotani H; Glover JP; Lois N; Robison WG
    J Ocul Pharmacol Ther; 1998 Apr; 14(2):169-80. PubMed ID: 9572543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new approach against sugar cataract through aldose reductase inhibitors.
    Banditelli S; Boldrini E; Vilardo PG; Cecconi I; Cappiello M; Dal Monte M; Marini I; Del Corso A; Mura U
    Exp Eye Res; 1999 Nov; 69(5):533-8. PubMed ID: 10548473
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sorbinil protection of lens protein components and cell hydration during diabetic cataract formation.
    Beyer-Mears A; Cruz E; Nicolas-Alexandre J; Varagiannis E
    Pharmacology; 1982; 24(3):193-200. PubMed ID: 6803262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.